Saarma M - Search Results

1

Can Growth Factors Cure Parkinson's Disease?

Sidorova YA, Saarma M. Sidorova YA, et al. Among authors: saarma m. Trends Pharmacol Sci. 2020 Dec;41(12):909-922. doi: 10.1016/j.tips.2020.09.010. Epub 2020 Oct 22. Trends Pharmacol Sci. 2020. PMID: 33198924 Review.

2

GDNF family receptor complexes are emerging drug targets.

Bespalov MM, Saarma M. Bespalov MM, et al. Among authors: saarma m. Trends Pharmacol Sci. 2007 Feb;28(2):68-74. doi: 10.1016/j.tips.2006.12.005. Epub 2007 Jan 10. Trends Pharmacol Sci. 2007. PMID: 17218019 Review.

3

The structure of the glial cell line-derived neurotrophic factor-coreceptor complex: insights into RET signaling and heparin binding.

Parkash V, Leppänen VM, Virtanen H, Jurvansuu JM, Bespalov MM, Sidorova YA, Runeberg-Roos P, Saarma M, Goldman A. Parkash V, et al. Among authors: saarma m. J Biol Chem. 2008 Dec 12;283(50):35164-72. doi: 10.1074/jbc.M802543200. Epub 2008 Oct 8. J Biol Chem. 2008. PMID: 18845535 Free PMC article.

4

Heparin-binding determinants of GDNF reduce its tissue distribution but are beneficial for the protection of nigral dopaminergic neurons.

Piltonen M, Bespalov MM, Ervasti D, Matilainen T, Sidorova YA, Rauvala H, Saarma M, Männistö PT. Piltonen M, et al. Among authors: saarma m. Exp Neurol. 2009 Oct;219(2):499-506. doi: 10.1016/j.expneurol.2009.07.002. Epub 2009 Jul 15. Exp Neurol. 2009. PMID: 19615368

5

Persephin signaling through GFRalpha1: the potential for the treatment of Parkinson's disease.

Sidorova YA, Mätlik K, Paveliev M, Lindahl M, Piranen E, Milbrandt J, Arumäe U, Saarma M, Bespalov MM. Sidorova YA, et al. Among authors: saarma m. Mol Cell Neurosci. 2010 Jul;44(3):223-32. doi: 10.1016/j.mcn.2010.03.009. Epub 2010 Mar 27. Mol Cell Neurosci. 2010. PMID: 20350599

6

Heparan sulfate proteoglycan syndecan-3 is a novel receptor for GDNF, neurturin, and artemin.

Bespalov MM, Sidorova YA, Tumova S, Ahonen-Bishopp A, Magalhães AC, Kulesskiy E, Paveliev M, Rivera C, Rauvala H, Saarma M. Bespalov MM, et al. Among authors: saarma m. J Cell Biol. 2011 Jan 10;192(1):153-69. doi: 10.1083/jcb.201009136. Epub 2011 Jan 3. J Cell Biol. 2011. PMID: 21200028 Free PMC article.

7

Prospects of Neurotrophic Factors for Parkinson's Disease: Comparison of Protein and Gene Therapy.

Domanskyi A, Saarma M, Airavaara M. Domanskyi A, et al. Among authors: saarma m. Hum Gene Ther. 2015 Aug;26(8):550-9. doi: 10.1089/hum.2015.065. Hum Gene Ther. 2015. PMID: 26176331 Review.

8

Therapeutic potential of the endoplasmic reticulum located and secreted CDNF/MANF family of neurotrophic factors in Parkinson's disease.

Voutilainen MH, Arumäe U, Airavaara M, Saarma M. Voutilainen MH, et al. Among authors: saarma m. FEBS Lett. 2015 Dec 21;589(24 Pt A):3739-48. doi: 10.1016/j.febslet.2015.09.031. Epub 2015 Oct 9. FEBS Lett. 2015. PMID: 26450777 Free article. Review.

9

Current disease modifying approaches to treat Parkinson's disease.

Lindholm D, Mäkelä J, Di Liberto V, Mudò G, Belluardo N, Eriksson O, Saarma M. Lindholm D, et al. Among authors: saarma m. Cell Mol Life Sci. 2016 Apr;73(7):1365-79. doi: 10.1007/s00018-015-2101-1. Epub 2015 Nov 30. Cell Mol Life Sci. 2016. PMID: 26616211 Review.

10

Parkinson's disease: towards better preclinical models and personalized treatments.

Lindholm D, Mäkelä J, Di Liberto V, Mudò G, Belluardo N, Eriksson O, Saarma M. Lindholm D, et al. Among authors: saarma m. Cell Mol Life Sci. 2016 Apr;73(7):1383-5. doi: 10.1007/s00018-016-2141-1. Epub 2016 Feb 3. Cell Mol Life Sci. 2016. PMID: 26841827 Free article. No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

298 results

Search Page